Yujin Bhatt

Yujin Bhatt studies the mechanisms by which non-alcoholic steatohepatitis (NASH) drives hepatocellular carcinoma development, even in patients without advanced cirrhosis. His research has characterized inflammatory and metabolic pathways linking lipotoxicity, oxidative stress, and hepatocyte injury to oncogenic transformation in NASH. He has defined the unique molecular landscape of NASH-HCC compared to viral HCC, revealing distinct therapeutic vulnerabilities. His work informs surveillance strategies and chemopreventive approaches for HCC in the burgeoning NASH population.